article thumbnail

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Cannabis Law Report

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97
article thumbnail

Who’s Really Buying CBD? And Why?

Cannabis Law Report

Regarding unregulated wellness products and the Food and Drug administration, there’s been a long-standing issue concerning claims being made, a reality the cannabinoid-infused industry must reckon with. I’ve heard all the pitches in retail and ecommerce. If there’s something out there that can help them, they deserve access.

CBD 75
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Oregon Cannabis: State of the State (2021)

Canna Law Blog

A total of 76 farms declined access to their properties, and inspectors were unable to contact an additional 23 locations. These changes cover artificially derived cannabinoids, packaging and labeling, concentration limits, retailer delivery and quite a bit more. The Commission’s summary of that effort is here. Big names in the news.

Hemp 84
article thumbnail

Supreme Cannabis to acquire Truverra as it prepares for Legalization 2.0 and Global Medical Markets

Cannabis Law Report

Located in Toronto , Truverra is a private cannabis company, serving the Canadian and international cannabis markets through its wholly-owned subsidiaries, Canadian Clinical Cannabinoids Inc. (“CCC”) and Truverra ( Europe ) B.V. (“Truverra Europe”). Based in the Netherlands , Truverra ( Europe ) B.V.

article thumbnail

Canopy Growth posts CA$1.7 billion annual loss

Cannabis Law Report

Tool captures point of sale data from an average of 29% of stores in Alberta, British Columbia, Saskatchewan, Manitoba and Newfoundland & Labrador, point of sale data from 100% of stores in New Brunswick, Nova Scotia and Prince Edward Island, as well as depletions and ecommerce sales data from the OCS. Net revenue. Webcast Information.

Data 95
article thumbnail

Kanabo’s CBD Line Available in the UK on Handpicked CBD

Cannabis Law Report

The high-quality pure hemp distillate CBD formulas are market leading with up to 86% cannabinoids and the vaporisation of CBD means it is fast acting compared to other products like tinctures or edibles. Consumers now have access to the strongest yet non-intoxicating CBD formulas with only the highest quality of ingredients.

CBD 52